Sumitomo Pharma Co., Ltd. (OTCMKTS:DNPUF) Sees Significant Increase in Short Interest

Sumitomo Pharma Co., Ltd. (OTCMKTS:DNPUF – Get Free Report) was the recipient of a large growth in short interest during the month of October. As of October 30th, there was short interest totaling 1,826,155 shares, a growth of 50.5% from the October 15th total of 1,213,493 shares. Based on an average trading volume of 23,351 shares, the days-to-cover ratio is presently 78.2 days.

Sumitomo Pharma Stock Performance

Shares of OTCMKTS DNPUF opened at $11.91 on Tuesday. Sumitomo Pharma has a 52-week low of $8.40 and a 52-week high of $19.20. The firm has a 50 day moving average price of $10.54 and a two-hundred day moving average price of $10.89.

About Sumitomo Pharma

(Get Free Report)

Sumitomo Pharma Co., Ltd. is a Japanese pharmaceutical company engaged in the research, development, manufacture and commercialization of prescription medicines. Its portfolio and development activities have focused on psychiatric and neurological disorders, oncology, gynecological health and other areas of significant unmet medical need. The company also conducts research in regenerative medicine and cell therapy. The company has marketed medicines including Latuda (lurasidone), an antipsychotic used in the treatment of schizophrenia and bipolar depression, as well as products for conditions such as overactive bladder and other specialized therapeutic areas.

See Also

Receive News & Ratings for Sumitomo Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sumitomo Pharma and related companies with MarketBeat.com's FREE daily email newsletter.